ALXN

Alexion Pharmaceuticals, Inc. News Headlines

$188.96
*  
6.88
3.78%
Get ALXN Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading ALXN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALXN After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Alexion's Rare Disease Model Analyzed
12/18/2014 3:23:00 PM - Seeking Alpha


Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog
12/17/2014 10:26:00 AM - Investopedia


Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog
12/17/2014 10:26:00 AM - Zacks.com


3 Companies Growing Faster Than MannKind Corporation
12/17/2014 7:03:02 AM - Motley Fool


Alexion Announces New Share Repurchase Program of $500M - Analyst Blog
12/16/2014 6:55:00 PM - Zacks.com


Alexion Announces New Share Repurchase Program of $500M - Analyst Blog
12/16/2014 6:55:00 AM - Investopedia


Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog
12/15/2014 6:15:00 PM - Zacks.com


Alexion Pharma To Repurchase Up To $500 Mln Of Stock - Quick Facts
12/15/2014 6:40:00 AM - RTT News


Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog
12/15/2014 6:15:00 AM - Investopedia


ChemoCentryx: Can It Break Into The Soliris Market?
12/11/2014 3:08:00 PM - Seeking Alpha


Oil-Related Stocks and Currencies Suffer as Oil Hits Five-Year Low
12/11/2014 5:05:00 AM - Dow Jones Business News


Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY
12/8/2014 10:37:05 AM - GuruFocus


Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study - Analyst Blog
12/3/2014 10:51:00 AM - Zacks.com


Stock Market News for December 03, 2014 - Market News
12/3/2014 10:10:00 AM - Zacks.com


Valeant's Onexton Gel Gets FDA Approval for Acne - Analyst Blog
12/1/2014 6:30:00 PM - Zacks.com


Alexion's Soliris Gets Final Positive NICE Recommendation - Analyst Blog
11/28/2014 5:00:00 PM - Zacks.com


Health Care Sector Update for 11/28/2014: ALXN, NVS, DVAX
11/28/2014 9:11:29 AM - MT Newswires


NICE supports the commission of Soliris for aHUS
11/27/2014 12:11:00 PM - Seeking Alpha


Alexion Pharma : NICE Confirms Soliris Very Effective Treatment For AHUS
11/27/2014 5:25:00 AM - RTT News


Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog
11/26/2014 5:10:00 PM - Zacks.com


Marina Biotech: A Forgotten And Grossly Undervalued Game-Changer
11/25/2014 10:30:00 AM - Seeking Alpha


Alexion Says Soliris Granted Orphan Drug Status By Japan's MHLW - Quick Facts
11/25/2014 6:39:00 AM - RTT News


Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2014 Update
11/25/2014 3:06:00 AM - Seeking Alpha


Stock Market News for November 19, 2014 - Market News
11/19/2014 10:10:00 AM - Zacks.com


Why Celldex Therapeutics' Stock Is Now Ready For Takeoff
11/18/2014 2:44:00 PM - Seeking Alpha